Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury

September 5, 2018 updated by: M J Harbert, Sharp HealthCare
The purpose of this study is early identification of asphyxiated newborns through eeg starting in the delivery room.

Study Overview

Status

Completed

Detailed Description

There is a need for a reliable detector of birth asphyxia so that newborns with birth asphyxia can have timely and accurate diagnosis to receive therapeutic hypothermia within 6 hrs of life, which has been shown to significantly reduce deaths and improve long term developmental outcomes.

This study is designed to record EEG during birth transition through the first 10 minutes of life.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92123
        • Sharp Mary Birch Hospital for Women and Newborns

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 months to 10 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Term infants at delivery (37-44 weeks gestational age)

Description

Inclusion Criteria: Term infants

  • Signed Informed consent

Exclusion Criteria:

  • Known congenital anomalies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
EES
Epidermal Electronic System
Hydrogel Electrode
Hydrogel based EEG electrode

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EEG recorded
Time Frame: Birth to 10 minutes of life
May be up to 60 minutes if applicable
Birth to 10 minutes of life

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin irritation from EES or hydrogel electrodes
Time Frame: 60 minutes of life
Redness, excoriation
60 minutes of life
Successful adhesion of EES to skin
Time Frame: 60 minutes of life
Redness, excoriation
60 minutes of life

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Apgar scores
Time Frame: Birth to 10 minutes of life
At 1, 5, 10, 15 and 20 minutes of life if done
Birth to 10 minutes of life
Blowby oxygen at delivery
Time Frame: Birth to 10 minutes of life
Birth to 10 minutes of life
Intubation at delivery
Time Frame: Birth to 10 minutes of life
for meconium suctioning or ventilation purposes
Birth to 10 minutes of life
Positive Pressure Ventilation
Time Frame: Birth to 10 minutes of life
By bag and mask or endotracheal tube
Birth to 10 minutes of life
Continuous Positive Airway Pressure
Time Frame: Birth to 10 minutes of life
Birth to 10 minutes of life
Epinephrine administration
Time Frame: Birth to 10 minutes of life
Birth to 10 minutes of life
Sodium bicarbonate administration
Time Frame: Birth to 10 minutes of life
Birth to 10 minutes of life
Normal saline bolus administration
Time Frame: Birth to 10 minutes of life
Birth to 10 minutes of life
Chest compressions
Time Frame: Birth to 10 minutes of life
Birth to 10 minutes of life
Near-infrared spectroscopy measurement
Time Frame: Birth to 10 minutes of life. May extend to 60 minutes of life if applicable.
Non-invasive brain tissue oximetry recording
Birth to 10 minutes of life. May extend to 60 minutes of life if applicable.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mary J Harbert, MD, Sharp Mary Birch Hospital for Women & Newborns

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 25, 2015

Primary Completion (Actual)

August 31, 2017

Study Registration Dates

First Submitted

March 31, 2015

First Submitted That Met QC Criteria

May 12, 2015

First Posted (Estimate)

May 15, 2015

Study Record Updates

Last Update Posted (Actual)

September 7, 2018

Last Update Submitted That Met QC Criteria

September 5, 2018

Last Verified

September 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Encephalopathy

3
Subscribe